RNA processing questions are a classic “everything sounds right” trap: capping, splicing, and polyadenylation all happen to pre-mRNA, all occur in the nucleus, and all affect translation—but in different ways. The fastest way to stop missing these is to train yourself to read each answer choice like a mini-mechanism.
Tag: Biochemistry > DNA/RNA/Nucleic Acids
The Clinical Vignette (Q-bank style)
A 6-year-old child has recurrent sinopulmonary infections and failure to thrive. Genetic testing reveals a mutation affecting a small nuclear ribonucleoprotein (snRNP) involved in pre-mRNA processing. Analysis of the patient’s mRNA shows abnormal retention of intronic sequences and reduced production of functional protein from multiple genes.
Which of the following is most directly impaired?
A. Addition of a 7-methylguanosine cap to the 5′ end of mRNA
B. Cleavage of phosphodiester bonds by RNA polymerase II to remove introns
C. Spliceosome-mediated removal of introns via lariat formation at an adenine residue
D. Addition of a poly(A) tail to the 3′ end of mRNA to facilitate nuclear export
E. Editing of tRNA anticodons to ensure accurate codon recognition
Correct Answer: C. Spliceosome-mediated removal of introns via lariat formation at an adenine residue
Why this is correct
The stem points you straight to the spliceosome:
- snRNPs (small nuclear ribonucleoproteins) are core components of the spliceosome.
- Intronic retention = failed splicing.
- The hallmark mechanism: introns are removed through lariat formation initiated by the 2′-OH of an intronic adenine at the branch point.
High-yield splicing mechanism (Step 1 gold)
Splicing depends on conserved sequences:
| Splicing element | High-yield sequence/feature |
|---|---|
| 5′ splice site (donor) | Usually GU at the beginning of the intron |
| Branch point | Adenine (A) within the intron |
| 3′ splice site (acceptor) | Usually AG at the end of the intron |
Two transesterification reactions:
- The 2′-OH of branch point A attacks the 5′ splice site → forms a lariat (2′–5′ phosphodiester bond).
- The freed 3′-OH of the upstream exon attacks the 3′ splice site → exons ligate, intron lariat released.
USMLE associations
- Spliceosome = snRNPs (U1, U2, U4, U5, U6)
- Splicing occurs in the nucleus (for eukaryotic pre-mRNA).
- Introns are common in eukaryotes; most prokaryotic mRNA is not spliced.
Why Every Distractor Is Wrong (and what it was trying to test)
A. Addition of a 7-methylguanosine cap to the 5′ end of mRNA
Why it’s wrong
The vignette specifically implicates snRNPs and shows introns retained. That’s splicing, not capping.
What you should recall about 5′ capping
- Added co-transcriptionally to pre-mRNA shortly after transcription begins.
- The cap is 7-methylguanosine (m7G) linked via an unusual 5′–5′ triphosphate bond.
- Functions:
- Protects mRNA from 5′ exonucleases
- Helps with ribosome recognition/translation initiation
- Helps with nuclear export (via cap-binding proteins)
How it appears in questions
- Loss of cap → unstable mRNA, reduced translation, increased degradation.
- It would not specifically cause intron retention.
B. Cleavage of phosphodiester bonds by RNA polymerase II to remove introns
Why it’s wrong
RNA polymerase II does not excise introns. It synthesizes RNA from a DNA template (transcription), but the spliceosome removes introns.
What this distractor is testing
- Confusing transcription machinery (RNA pol II) with RNA processing machinery (spliceosome/snRNPs).
- RNA polymerase II key association:
- Transcribes mRNA (and some snRNA)
- Inhibited by α-amanitin (from Amanita phalloides)
If the question wanted RNA pol II, you’d see something like:
- “Marked decrease in mRNA synthesis”
- “Sensitivity to α-amanitin”
- “No pre-mRNA produced,” rather than “pre-mRNA with introns retained”
D. Addition of a poly(A) tail to the 3′ end of mRNA to facilitate nuclear export
Why it’s wrong
Polyadenylation affects stability, translation efficiency, and export, but it does not directly explain intronic retention or a defect in snRNPs.
High-yield polyadenylation facts
- Happens at the 3′ end after cleavage downstream of the AAUAAA signal (polyadenylation signal).
- Enzyme: poly(A) polymerase adds adenine residues (does not require a template).
- Functions:
- Protects from 3′ exonucleases
- Improves translation efficiency
- Supports nuclear export and mRNA stability
Common USMLE twist: histones
- Replication-dependent histone mRNAs lack poly(A) tails (they end in a stem-loop instead).
If a question mentions histone mRNA processing, polyadenylation may be the point.
E. Editing of tRNA anticodons to ensure accurate codon recognition
Why it’s wrong
This is about tRNA, not pre-mRNA, and it doesn’t involve snRNPs or intron retention in mRNA.
What you should think when you see tRNA
- tRNA processing (in nucleus for eukaryotes) includes trimming and base modification.
- Aminoacyl-tRNA synthetases charge tRNAs; errors here cause mistranslation.
- Classic Step 1 tie-in:
- Some antibiotics target tRNA binding sites on ribosomes (more Step 2 pharm/micro flavor).
If the stem had “misincorporation of amino acids” or “defective charging,” then we’d pivot toward aminoacyl-tRNA synthetase, not splicing.
Rapid-Fire High-Yield Summary (what to memorize)
Pre-mRNA processing in eukaryotes (nucleus)
- 5′ cap (m7G): protection + translation initiation + export
- Splicing (spliceosome/snRNPs): remove introns (GU…A…AG), lariat at branch point A
- 3′ poly(A) tail: stability + translation efficiency + export; signal AAUAAA
Common exam pattern recognition
- Introns retained / abnormal exon skipping → splicing defect (spliceosome/snRNPs)
- Rapid mRNA degradation from 5′ end → capping defect
- Low mRNA stability / shortened half-life → consider poly(A) tail defect
- Global loss of mRNA synthesis → RNA polymerase II problem (think α-amanitin)
Test-Day Tip: How to “interrogate” each answer choice
When stuck, ask one question per process:
- Capping: “Does this primarily affect 5′ protection and translation initiation?”
- Splicing: “Does the stem mention introns/exons, snRNPs, or lariat/branch point?”
- Poly(A): “Does this sound like a 3′ stability/export problem and mention AAUAAA?”
- tRNA: “Is this really about translation accuracy rather than mRNA structure?”
That’s how you turn a messy RNA processing question into a clean, stepwise elimination.